Nicholas A.J. Botwood, Head of R&D, CMO at Syndax Pharmaceuticals, sold SNDX on Jun 12, 2026
Data as of Oct 27
▼ SELL$567K31,235 shares at $18.14Nicholas A.J. Botwood Head of R&D, CMOSNDX Syndax Pharmaceuticals Inc
- Traded
- Jun 12, 2026
- Disclosed
- Jun 12, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
SNDX since disclosure
−25.0%
after the sale
Similar stocks (SPY) since disclosure
+3.8%
S&P 500 (SPY)
Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLNicholas A.J. Botwood Head of R&D, CMOSNDX Syndax Pharmaceuticals Inc$617Kdisclosed Jun 12 · filed 1 day after the trade